Intraprostatic Botulinum Toxin injection in patients with benign prostatic enlargement
2009
Botulinum Toxin Injection for Benign Prostatic Enlargement
Sample size: 30
publication
Evidence: moderate
Author Information
Author(s): Ilie CP, Chancellor MB, Chuang YC, Mischianu D
Primary Institution: Carol Davila University of Medicine and Pharmacy
Hypothesis
Can botulinum toxin type A (BTX–A) alleviate symptoms of benign prostatic hyperplasia (BPH)?
Conclusion
BTX–A injections are effective in relieving symptoms associated with BPH.
Supporting Evidence
- BTX–A injections led to a significant reduction in prostate volume.
- Patients reported symptomatic relief after BTX–A treatment.
- The study showed a decrease in post-void residual volume after treatment.
Takeaway
Doctors can use a special medicine called botulinum toxin to help men with prostate problems feel better.
Methodology
The study involved injecting BTX–A into the prostate of men with BPH and measuring symptom relief and prostate volume changes.
Limitations
The study suggests the need for larger randomized clinical trials to confirm findings.
Participant Demographics
Men over 50 years of age with benign prostatic hyperplasia.
Statistical Information
P-Value
p=0.00001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website